In8Bio INAB Peer Comparison

NASDAQ INAB
$1.08 -0.06 (-5.26%)
At close: Sep 9, 2026 · 4:00 PM EDT
Peer Comparison

300 Comparable Companies

Industry Gene and Cell Therapy

In8Bio, Inc. (INAB) is the 278th largest of 300 Gene and Cell Therapy companies by market capitalisation, at 23.36 Mn, behind Estrella Immunopharma, Inc. at 28.27 Mn. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 KRYS Krystal Biotech, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 10.60 Bn 43.81 24.07 9.76 Bn
2 CRSP CRISPR Therapeutics AG primary H-03 Pharmaceuticals and Biotechnology HG-01 5.39 Bn -11.13 402.68 5.39 Bn
3 IOVA Iovance Biotherapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 3.98 Bn -18.93 12.25 3.68 Bn
4 LEGN Legend Biotech Corp primary H-03 Pharmaceuticals and Biotechnology HG-01 3.97 Bn -188.37 3.12 3.00 Bn
5 QURE uniQure N.V. primary H-03 Pharmaceuticals and Biotechnology HG-01 3.09 Bn -14.99 165.24 3.09 Bn
6 BEAM Beam Therapeutics Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 3.06 Bn -36.22 19.63 3.06 Bn
7 PGEN Precigen, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 2.54 Bn -7.53 29.65 2.54 Bn
8 SRPT Sarepta Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -17.30 1.20 1.58 Bn
9 VCEL Vericel Corp primary H-03 Pharmaceuticals and Biotechnology HG-01 2.06 Bn 81.80 6.71 1.89 Bn
10 TSHA Taysha Gene Therapies, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.82 Bn -13.81 332.12 1.82 Bn
11 NTLA Intellia Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.78 Bn -4.26 29.98 1.78 Bn
12 SLDB Solid Biosciences Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -7.22 — 1.47 Bn
13 MGTX MeiraGTx Holdings plc primary H-03 Pharmaceuticals and Biotechnology HG-01 1.31 Bn 7.69 3.26 1.17 Bn
14 IMTX Immatics N.V. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.28 Bn -4.85 26.37 0.82 Bn
15 SANA Sana Biotechnology, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.15 Bn -5.31 — 1.15 Bn
16 FDMT 4D Molecular Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.05 Bn -5.87 11.43 0.69 Bn
17 PROK Prokidney Corp. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.03 Bn -2.81 1,256.22 1.03 Bn
18 IMMX Immix Biopharma, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 1.00 Bn -28.03 — 1.00 Bn
19 CADL Candel Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -14.44 — 0.97 Bn
20 NGNE Neurogene Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.87 Bn -7.79 — 0.87 Bn
21 AUTL Autolus Therapeutics plc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.80 Bn -2.32 7.09 0.59 Bn
22 ALLO Allogene Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.68 Bn -3.91 146.62 0.68 Bn
23 PRME Prime Medicine, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.67 Bn -3.49 164.19 0.67 Bn
24 CABA Cabaletta Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -2.86 — 0.59 Bn
25 BNTC Benitec Biopharma Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -12.59 — 0.58 Bn
26 CAPR Capricor Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.55 Bn -4.31 — 0.55 Bn
27 KYTX Kyverna Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -3.29 — 0.51 Bn
28 RGNX REGENXBIO Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.48 Bn -2.66 2.56 0.38 Bn
29 OCGN Ocugen, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -5.63 100.68 0.36 Bn
30 ARTV Artiva Biotherapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.86 — 0.44 Bn
31 RCKT Rocket Pharmaceuticals, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -25.25 — 0.42 Bn
32 IRD Opus Genetics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.59 39.16 0.30 Bn
33 LXEO Lexeo Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -4.80 — 0.38 Bn
34 IPSC Century Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -3.95 — 0.12 Bn
35 ABEO Abeona Therapeutics Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -3.16 13.45 0.20 Bn
36 LYEL Lyell Immunopharma, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -1.36 12,452.40 0.34 Bn
37 CLLS Cellectis S.A. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -7.83 5.52 0.16 Bn
38 EDIT Editas Medicine, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.30 Bn — — 0.15 Bn
39 FATE Fate Therapeutics Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -2.38 44.59 0.29 Bn
40 NWBO Northwest Biotherapeutics Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -7.18 130.59 0.28 Bn
41 RNAC Cartesian Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -2.51 188.53 0.28 Bn
42 LCTX Lineage Cell Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -11.75 20.88 0.22 Bn
43 MEOBF Mesoblast Ltd primary H-03 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -4.28 2.05 0.14 Bn
44 TARA Protara Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.42 — 0.23 Bn
45 VYGR Voyager Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.58 6.23 0.10 Bn
46 NKTX Nkarta, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.53 — 0.21 Bn
47 DTIL Precision Biosciences Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -5.69 4.38 0.11 Bn
48 HUMA Humacyte, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -1.17 78.59 0.17 Bn
49 CRBU Caribou Biosciences, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -1.45 16.58 0.05 Bn
50 ZSQR Z Squared Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -7.61 55.90 0.14 Bn
51 TNYA Tenaya Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -1.43 114.21 0.15 Bn
52 ATRA Atara Biotherapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -6.24 23.69 0.13 Bn
53 ENGN enGene Therapeutics Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -0.97 — 0.12 Bn
54 ANIX Anixa Biosciences Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.96 — 0.10 Bn
55 ACET Adicet Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.04 — -0.03 Bn
56 INMB Inmune Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -3.23 — 0.05 Bn
57 INKT MiNK Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -5.04 — 0.06 Bn
58 APTN Adaptin Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -10.22 — 0.06 Bn
59 TCRX TScan Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.43 7.13 0.05 Bn
60 CELU Celularity Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.47 1.82 0.04 Bn
61 SGMOQ Sangamo Therapeutics, Inc primary H-03 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.36 1.13 0.02 Bn
62 MGX Metagenomi Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.47 2.02 0.04 Bn
63 TVGN Tevogen Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.27 — 0.03 Bn
64 ESLA Estrella Immunopharma, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.85 — 0.03 Bn
65 INAB In8Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.29 — 0.02 Bn
66 GNTA Genenta Science S.p.A. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -3.87 — 0.02 Bn
67 LGVN Longeveron Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.91 17.37 0.01 Bn
68 MRKR Marker Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.24 — 0.01 Bn
69 PASG Passage BIO, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.38 — 0.01 Bn
70 PLUR Pluri Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn 0.00 10.13 0.01 Bn
71 ADIA Adia Nutrition, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -75.51 69.62 0.01 Bn
72 BCDA BioCardia, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.76 — 0.01 Bn
73 FBLG FibroBiologics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.68 — 0.01 Bn
74 SNTI Senti Biosciences Holdings, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.16 604.57 0.01 Bn
75 GDTC CytoMed Therapeutics Ltd primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -3.25 40.49 0.01 Bn
76 ZEOX Zeo ScientifiX, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -2.14 1.29 0.01 Bn
77 LNAI Lunai Bioworks Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.06 87.61 0.00 Bn
78 TPST Tempest Therapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.28 — 0.00 Bn
79 PMCB PharmaCyte Biotech, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.18 — 0.00 Bn
80 MBIO Mustang Bio, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.20 — 0.00 Bn
81 ISCO International Stem Cell CORP primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -10.41 0.35 0.00 Bn
82 CLDI Calidi Biotherapeutics, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.08 — 0.00 Bn
83 GNPX Genprex, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — -0.01 Bn
84 CELZ Creative Medical Technology Holdings, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.21 492.05 0.00 Bn
85 RMTG Regenerative Medical Technology Group Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.11 0.12 0.00 Bn
86 ERNAW Ernexa Therapeutics Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 — 0.00 Bn
87 BRTX BioRestorative Therapies, Inc. primary H-03 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 0.17 0.00 Bn
88 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 663.08 Bn 31.49 6.77 642.33 Bn
89 ABBV AbbVie Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 453.04 Bn 71.80 7.04 446.51 Bn
90 MRK Merck & Co., Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 370.87 Bn 117.16 5.57 363.78 Bn
91 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 236.37 Bn 27.00 6.20 222.38 Bn
92 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 187.38 Bn -64.83 6.15 184.12 Bn
93 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 138.36 Bn 31.45 10.99 130.51 Bn
94 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 85.09 Bn 19.66 5.48 77.10 Bn
95 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 63.93 Bn 36.92 12.23 58.75 Bn
96 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 58.07 Bn -18.38 26.07 52.94 Bn
97 SNY Sanofi secondary H-01 Pharmaceuticals and Biotechnology HG-01 53.95 Bn 11.58 1.01 46.98 Bn
98 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.34 Bn 60.81 2.45 38.68 Bn
99 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 35.59 Bn 45.89 7.41 32.28 Bn
100 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 32.63 Bn 39.08 3.25 31.34 Bn
101 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.57 Bn -31.36 24.23 26.41 Bn
102 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 26.24 Bn -14.72 8.48 12.58 Bn
103 INCY Incyte Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 25.47 Bn 15.75 4.38 20.94 Bn
104 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 25.24 Bn -16.96 2,310.98 25.93 Bn
105 UTHR UNITED THERAPEUTICS Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 20.81 Bn 15.85 6.60 18.15 Bn
106 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 18.70 Bn 22.24 2.20 18.30 Bn
107 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 16.77 Bn 18.91 11.83 15.82 Bn
108 JAZZ Jazz Pharmaceuticals plc secondary H-01 Pharmaceuticals and Biotechnology HG-01 16.02 Bn 16.58 3.48 14.40 Bn
109 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.81 Bn 22.28 4.69 15.42 Bn
110 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.77 Bn -49.43 12.28 14.93 Bn
111 EXEL Exelixis, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 14.69 Bn 17.20 6.03 13.85 Bn
112 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.62 Bn -21.18 20.50 13.91 Bn
113 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.96 Bn — — 13.27 Bn
114 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.88 Bn 176.35 3.78 12.00 Bn
115 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.57 Bn 31.25 7.55 12.34 Bn
116 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.19 Bn -45.49 18.20 10.58 Bn
117 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.15 Bn 74.93 14.45 11.63 Bn
118 AAVXF Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
119 AXSM Axsome Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.81 Bn -69.64 13.92 10.49 Bn
120 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 10.51 Bn 19.74 3.34 9.91 Bn
121 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
122 GPCR Structure Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.11 Bn -54.84 — 10.11 Bn
123 RDY Dr Reddys Laboratories Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 9.99 Bn 789.75 2.73 9.85 Bn
124 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.82 Bn -26.87 — 9.06 Bn
125 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.62 Bn -45.28 11.01 7.57 Bn
126 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.42 Bn 87.02 33.42 9.42 Bn
127 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.86 Bn -8.36 — 8.86 Bn
128 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.57 Bn 17.97 10.72 7.89 Bn
129 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.51 Bn -8.55 51.33 8.15 Bn
130 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.10 Bn -14.99 — 8.10 Bn
131 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.84 Bn -42.14 — 7.84 Bn
132 GIFLF Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
133 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.07 Bn -33.52 29.47 6.74 Bn
134 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.97 Bn -734.96 5,007.81 6.97 Bn
135 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.73 Bn -17.90 — 6.73 Bn
136 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.59 Bn -29.38 1,058.74 6.59 Bn
137 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.53 Bn -7.43 10.57 6.10 Bn
138 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.96 Bn -16.08 — 5.96 Bn
139 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn -33.18 1,163.52 5.66 Bn
140 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.82 Bn — — 4.09 Bn
141 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn -16.41 — 5.78 Bn
142 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.77 Bn 15.04 5.72 3.55 Bn
143 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.69 Bn 29.05 19.58 4.33 Bn
144 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.06 Bn -17.55 — 5.06 Bn
145 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.68 Bn -23.96 — 4.68 Bn
146 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.63 Bn — — 4.23 Bn
147 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.16 Bn -13.51 402.01 4.16 Bn
148 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.07 Bn -7.58 — 4.07 Bn
149 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn -7.78 — 4.02 Bn
150 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.84 Bn -16.67 16.41 3.01 Bn
151 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.80 Bn -31.20 — 3.80 Bn
152 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.79 Bn -32.98 70.47 2.78 Bn
153 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.77 Bn -8.13 32.18 3.06 Bn
154 TLPPF Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.72 Bn -521.64 4.64 3.43 Bn
155 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.56 Bn -8.16 987.61 3.56 Bn
156 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.50 Bn -21.21 52.94 3.50 Bn
157 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.11 Bn -10.05 19,714.47 3.11 Bn
158 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.04 Bn -15.22 — 3.04 Bn
159 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.03 Bn -11.21 593.06 2.51 Bn
160 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.00 Bn 109.49 6.47 2.76 Bn
161 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -28.23 — 2.96 Bn
162 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.94 Bn -15.57 6.55 2.24 Bn
163 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.80 Bn -80.78 — 2.80 Bn
164 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.73 Bn -22.89 553.22 2.73 Bn
165 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.71 Bn -8.51 73.73 2.27 Bn
166 TAK Takeda Pharmaceutical Co Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.67 Bn 4.61 0.06 -3.12 Bn
167 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.60 Bn -6.02 36.49 2.60 Bn
168 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.59 Bn -174.08 10.31 2.48 Bn
169 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.59 Bn -6.44 — 2.59 Bn
170 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.54 Bn -6.59 4.75 2.19 Bn
171 SUPN Supernus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.53 Bn -29.70 3.21 2.16 Bn
172 BEIGF BeOne Medicines Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.48 Bn 3.74 0.40 -2.62 Bn
173 HRMY Harmony Biosciences Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.46 Bn 13.72 2.56 1.65 Bn
174 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.45 Bn -20.64 44.92 1.77 Bn
175 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2,975.41 — 2.38 Bn
176 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.37 Bn -4.03 — 2.10 Bn
177 NUVB Nuvation Bio Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.36 Bn -21.96 13.89 2.36 Bn
178 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.34 Bn -7.91 44.88 2.34 Bn
179 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.30 Bn -10.51 — 1.93 Bn
180 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.22 Bn -9.16 — 2.22 Bn
181 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.19 Bn -15.84 109.75 2.19 Bn
182 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.17 Bn 13.20 4.23 2.03 Bn
183 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn 0.17 0.34 0.66 Bn
184 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.16 Bn -35.67 11.42 2.05 Bn
185 AUPH Aurinia Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.14 Bn 6.66 6.86 1.69 Bn
186 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -14.21 56.15 1.81 Bn
187 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -4.99 2,082.32 2.08 Bn
188 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -12.36 18.84 1.60 Bn
189 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn -4.78 20.06 1.97 Bn
190 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.94 Bn -3.72 35.35 1.39 Bn
191 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn -7.59 6.35 1.93 Bn
192 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn -9.47 67.43 1.57 Bn
193 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn -101.76 4.32 0.98 Bn
194 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn -6.99 — 1.32 Bn
195 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn -10.09 7.27 1.29 Bn
196 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.80 Bn -4.55 — 1.80 Bn
197 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.78 Bn -14.23 1,370.98 1.78 Bn
198 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.75 Bn -27.67 — 1.39 Bn
199 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.74 Bn -207.39 1,008.79 1.73 Bn
200 GLPGF Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
201 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -12.73 — 1.71 Bn
202 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -6.79 4.07 0.97 Bn
203 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -118.55 16.97 1.68 Bn
204 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.66 Bn -9.11 20.12 1.38 Bn
205 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn -68.24 8.28 1.36 Bn
206 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
207 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.53 Bn -8.49 — 1.53 Bn
208 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -11.47 969.66 1.31 Bn
209 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -3.37 2.10 1.22 Bn
210 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.50 Bn -9.00 — 1.50 Bn
211 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -14.58 72.74 1.45 Bn
212 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -6.70 — 1.42 Bn
213 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn -5.85 165.97 0.88 Bn
214 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn 80.09 35.55 1.37 Bn
215 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -1.48 — 1.36 Bn
216 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn -8.83 — 1.33 Bn
217 SDGR Schrodinger, Inc. secondary T-27 Vertical Software TG-05 1.32 Bn -27.62 5.09 0.90 Bn
218 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.28 Bn -4.18 — 0.74 Bn
219 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -7.93 — 1.26 Bn
220 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -4.90 — 1.26 Bn
221 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -28.78 3.20 1.15 Bn
222 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn -18.17 — 1.25 Bn
223 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.24 Bn -12.42 51.51 1.24 Bn
224 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.21 Bn -27.82 — 1.00 Bn
225 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -20.55 — 1.18 Bn
226 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -9.12 41.06 0.55 Bn
227 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.10 Bn -9.77 — 1.10 Bn
228 OKYO OKYO Pharma Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.06 Bn -118.02 — 1.06 Bn
229 PCRX Pacira BioSciences, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 1.05 Bn 71.04 1.41 0.80 Bn
230 ABUS Arbutus Biopharma Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 6.67 5.60 0.93 Bn
231 GERN Geron Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn -15.63 4.14 0.71 Bn
232 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.00 Bn -72.45 — 0.95 Bn
233 ARDX Ardelyx, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -16.83 2.09 0.66 Bn
234 WVE Wave Life Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -4.90 14.37 0.57 Bn
235 RIGL Rigel Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.91 Bn 2.80 3.28 0.81 Bn
236 TBPH Theravance Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.89 Bn 20.87 8.50 0.50 Bn
237 STTK Shattuck Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn -16.32 881.20 0.88 Bn
238 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.86 Bn -11.07 104.97 0.86 Bn
239 ANNX Annexon, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.85 Bn -4.78 — 0.85 Bn
240 AVTX Avalo Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.84 Bn -8.36 — 0.84 Bn
241 CTMX CytomX Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.81 Bn -10.71 44.17 0.48 Bn
242 ZURA Zura Bio Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -6.79 — 0.79 Bn
243 PHAR Pharming Group N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -124.74 2.37 0.63 Bn
244 AURA Aura Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -6.55 — 0.71 Bn
245 VSTM Verastem, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn -7.12 8.48 0.61 Bn
246 ZVRA Zevra Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.74 Bn 12.59 5.40 0.51 Bn
247 ASMB Assembly Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.73 Bn 554.70 9.71 0.41 Bn
248 BBOT BridgeBio Oncology Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn -3.61 — 0.49 Bn
249 IRWD Ironwood Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.70 Bn 3.17 1.81 0.62 Bn
250 SLN Silence Therapeutics plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.69 Bn -17.73 1,120.86 0.62 Bn
251 ALT Altimmune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn -8.59 — 0.67 Bn
252 CRMD CorMedix Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.65 Bn 5.25 1.75 0.40 Bn
253 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -362,547.56 — 0.64 Bn
254 OABI OmniAb, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -12.60 16.37 0.58 Bn
255 CTNM Contineum Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -10.36 — 0.63 Bn
256 ARVN Arvinas, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn 65.43 1.94 0.05 Bn
257 VALN Valneva SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -10.13 3.65 0.47 Bn
258 TECX Tectonic Therapeutic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -6.80 — 0.59 Bn
259 SGMT Sagimet Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -12.04 — 0.58 Bn
260 CBIO Crescent Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -3.91 557.79 0.41 Bn
261 IMUX Immunic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -4.84 — 0.56 Bn
262 FLGT Fulgent Genetics, Inc. secondary H-17 Healthcare Providers HG-04 0.54 Bn -6.55 2.25 0.28 Bn
263 OVID Ovid Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -16.03 326.79 0.40 Bn
264 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -10.27 78.36 0.28 Bn
265 PRTA Prothena Corp Public Ltd Co secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -11.66 9.32 0.22 Bn
266 DRUG Bright Minds Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -15.37 — 0.50 Bn
267 CNTN Canton Strategic Holdings, Inc. secondary T-58 Fintech TG-09 0.49 Bn -6.01 330.55 0.49 Bn
268 KMDA Kamada Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 15.82 2.57 0.42 Bn
269 PBYI Puma Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 16.24 2.11 0.39 Bn
270 RLMD Relmada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -8.13 — 0.47 Bn
271 NEUP Neuphoria Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.83 — 0.45 Bn
272 AVIR Atea Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -3.41 — 0.47 Bn
273 CCCC C4 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -4.85 13.19 0.21 Bn
274 ARCT Arcturus Therapeutics Holdings Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.72 15.31 0.26 Bn
275 CYPH Cypherpunk Technologies Inc. secondary T-58 Fintech TG-09 0.45 Bn 7.48 — 0.45 Bn
276 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.68 44.52 0.24 Bn
277 RZLT Rezolute, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -5.85 — 0.44 Bn
278 BIOA BioAge Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.58 42.40 0.44 Bn
279 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -7.97 19.43 0.16 Bn
280 CMPX Compass Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -5.45 — 0.43 Bn
281 ENTA Enanta Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -6.49 6.28 0.22 Bn
282 LRMR Larimar Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -2.27 — 0.24 Bn
283 EYPT EyePoint, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -1.28 139.55 0.21 Bn
284 WHWK Whitehawk Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -4.78 — 0.38 Bn
285 OFIX Orthofix Medical Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.38 Bn -8.69 0.45 0.27 Bn
286 HMDCF HUTCHMED (China) Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
287 DMAC DiaMedica Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -11.03 — 0.36 Bn
288 CATX Perspective Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -3.16 — 0.36 Bn
289 AGEN Agenus Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn 3.71 2.65 0.34 Bn
290 ELDN Eledon Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -4.13 — 0.34 Bn
291 EPRX Eupraxia Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -6.68 — 0.33 Bn
292 STRO Sutro Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -2.93 3.70 0.17 Bn
293 UPB Upstream Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -2.05 104.23 0.33 Bn
294 SABS SAB Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -4.33 — 0.31 Bn
295 TLSI TriSalus Life Sciences, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.31 Bn -4.97 6.82 0.26 Bn
296 GALT Galectin Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -10.84 — 0.31 Bn
297 BCYC Bicycle Therapeutics Plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -1.58 4.90 0.30 Bn
298 FIXX Q32 Bio Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 64.31 — 0.19 Bn
299 ACIU AC Immune SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -5.32 13.14 0.29 Bn
300 FHTX Foghorn Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -5.29 7.86 0.22 Bn